<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Samyang Biopharm - Diplomacy &amp; Trade</title>
	<atom:link href="https://dteurope.com/tag/samyang-biopharm/feed/" rel="self" type="application/rss+xml" />
	<link>https://dteurope.com</link>
	<description>Monthly in print &#124; Daily on the web</description>
	<lastBuildDate>Wed, 29 Jul 2020 07:27:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://dteurope.com/wp-content/uploads/cropped-dt_favicon-32x32.png</url>
	<title>Samyang Biopharm - Diplomacy &amp; Trade</title>
	<link>https://dteurope.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Samyang Biopharm: First European Unit in Gödöllő</title>
		<link>https://dteurope.com/company-briefs/samyang-biopharm-first-european-unit-in-godollo/</link>
		
		<dc:creator><![CDATA[D&#38;T]]></dc:creator>
		<pubDate>Wed, 29 Jul 2020 07:26:56 +0000</pubDate>
				<category><![CDATA[Company briefs]]></category>
		<category><![CDATA[Hungarian Investment Promotion Agency (HIPA)]]></category>
		<category><![CDATA[Pharmaceutical industry]]></category>
		<category><![CDATA[Republic of Korea]]></category>
		<category><![CDATA[Samyang Biopharm]]></category>
		<guid isPermaLink="false">https://dteurope.com/?p=21953</guid>

					<description><![CDATA[<p>South Korea-based Samyang Biopharm, specializing in medical devices, has selected Hungary for its first production unit in Europe. The HUF 8.6 billion (EUR 26.2 million) unit, will produce synthetic suture materials and create 55 new jobs in Gödöllő. The Hungarian government contributes about 15% of that amount (HUF 1.3 billion) in non-refundable support. The South [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://dteurope.com/company-briefs/samyang-biopharm-first-european-unit-in-godollo/">Samyang Biopharm: First European Unit in Gödöllő</a> appeared first on <a rel="nofollow" href="https://dteurope.com">Diplomacy &amp; Trade</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
